Search Results for: Medical uses
markets business unit headquartered in singapore, takeda's growth & emerging markets business unit (gem bu) has presence in almost geographies that includes brazil, china and russia, and area operations with hubs in asia pacific, icmea, and sam*. about us we are committed to addressing patient unmet medical
needs in the gem region, which includes those parts of the world with some of the heaviest healthcare burdens. we are primarily focused on delivering medical innovation to patients in the areas of oncology, gastroenterology, plasma derived therapies, and rare diseases. brazil, china and russia, and...
https://www.takeda.com/who-we-are/company-information/worldwide-offices/em-bu/
hamophilie-zentrum rhein main, mörfelden-walldorf, germany, vivantes klinikum im friedrichshain, berlin, germany, university of texas health science center at houston, houston, united states, university of cincinnati college of medicine and cancer and blood diseases institute, cincinnati children's hospital medical
center, cincinnati, united states, academy of medical sciences of ukraine, lviv, ukraine, baxalta us inc., a takeda company, cambridge, united states, baxalta innovations gmbh, a takeda company, vienna, austria, shire international gmbh, a takeda company, zurich, switzerland, katharine dormandy haemophilia...
https://abstracts.isth.org/abstract/personalizing-prophylaxis-with-rurioctocog-alfa-pegol-in-previously-treated-patients-with-severe-hemophilia-a-outcomes-from-the-phase-3b-continuation-and-phase-3-propel-studies/